BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26686083)

  • 1. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in Colorectal Cancer.
    Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GIPC1 regulates MACC1-driven metastasis.
    Siegel F; Schmidt H; Juneja M; Smith J; Herrmann P; Kobelt D; Sharma K; Fichtner I; Walther W; Dittmar G; Volkmer R; Rathjen FG; Schlag PM; Stein U
    Front Oncol; 2023; 13():1280977. PubMed ID: 38144523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EHF promotes colorectal carcinoma progression by activating TGF-β1 transcription and canonical TGF-β signaling.
    Wang L; Ai M; Nie M; Zhao L; Deng G; Hu S; Han Y; Zeng W; Wang Y; Yang M; Wang S
    Cancer Sci; 2020 Jul; 111(7):2310-2324. PubMed ID: 32372436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX19 Is a New Target of MACC1 and Promotes Colorectal Cancer Progression by Regulating Copper Transport in Mitochondria.
    Gao S; Zhang H; Zhang X; Wang J; Bai W; Jiang B
    J Nutr; 2024 Feb; 154(2):381-394. PubMed ID: 38141772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
    Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
    J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.
    Ha YJ; Park SH; Tak KH; Lee JL; Kim CW; Kim JH; Kim SY; Kim SK; Yoon YS
    Sci Rep; 2024 May; 14(1):12487. PubMed ID: 38816545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
    Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
    BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
    Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
    Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer.
    Erdem M; Lee KH; Hardt M; Regan JL; Kobelt D; Walther W; Mokrizkij M; Regenbrecht C; Stein U
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors.
    Tang J; Huang Q; Li X; Gu S
    Medicine (Baltimore); 2023 Sep; 102(37):e35122. PubMed ID: 37713832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis.
    Liu F; Wei X; Chen Z; Chen Y; Hu P; Jin Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10737-10752. PubMed ID: 37311985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer.
    Zhang XL; Hu LP; Yang Q; Qin WT; Wang X; Xu CJ; Tian GA; Yang XM; Yao LL; Zhu L; Nie HZ; Li Q; Xu Q; Zhang ZG; Zhang YL; Li J; Wang YH; Jiang SH
    Oncogene; 2021 Jun; 40(23):3959-3973. PubMed ID: 33986509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
    Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
    Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.
    Yan S; Schöpe PC; Lewis J; Putzker K; Uhrig U; Specker E; von Kries JP; Lindemann P; Omran A; Sanchez-Ibarra HE; Unger A; Zischinsky ML; Klebl B; Walther W; Nazaré M; Kobelt D; Stein U
    Biomed Pharmacother; 2023 Dec; 168():115698. PubMed ID: 37865992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.
    Lampis A; Hahne JC; Gasparini P; Cascione L; Hedayat S; Vlachogiannis G; Murgia C; Fontana E; Edwards J; Horgan PG; Terracciano L; Sansom OJ; Martins CD; Kramer-Marek G; Croce CM; Braconi C; Fassan M; Valeri N
    Cell Death Differ; 2021 Oct; 28(10):2970-2982. PubMed ID: 34226680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Characteristics and Clinical Correlations of BRD1 in Colorectal Cancer Samples.
    Li Z; Wang J; Ji Y; Song F
    Technol Cancer Res Treat; 2021; 20():15330338211039678. PubMed ID: 34482774
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yamamoto H; Miyoshi N; Mimori K; Hitora T; Tokuoka M; Fujino S; Ellis HL; Ishii H; Noura S; Ohue M; Yano M; Doki Y; Mori M
    Oncol Lett; 2014 Nov; 8(5):2305-2309. PubMed ID: 25295116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
    Yuzhalin AE; Lim SY; Gordon-Weeks AN; Fischer R; Kessler BM; Yu D; Muschel RJ
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G625-G639. PubMed ID: 31545917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.